Karachi, AGP Limitedinformed Pakistan Stock Exchange that extraordinary general meeting of the company is scheduled to be held on June 07, 2018 at Karachi.
The agenda of the meeting will be confirming the minutes of the 3rd Annual General Meeting held on February 12, 2018 and to elect Directors of the Company for a term of three years commencing from June 07, 2018, in accordance with the provisions of the section 159 of the Companies Act 2017.
Further, the closed period of the company is from May 25, 2018 to June 07, 2018 (both days inclusive).
AGP Limited (AGP) began its commercial operations in 1989 as an independent pharmaceutical manufacturing company in Karachi, Pakistan. It has steadily grown through manufacturing and marketing products under licensing arrangements with many companies of international repute and also through manufacturing and marketing its own brands. Today, it is one of the largest pharmaceutical companies in Pakistan, providing a broad range of pharmaceutical products. The determination to upgrade the pharmaceutical resources of Pakistan and improvement of the quality of life of a common man was the key motivating factors in the inception of AGP.
The operations of AGP include manufacturing, marketing and sales of pharmaceuticals and healthcare products in the domestic and export market. The delivery of AGP’s products, across the country, is managed by one of the largest and state of art pharmaceutical distribution set ups in Pakistan.